Lido Advisors, LLC Rigel Pharmaceuticals Inc Transaction History

Lido Advisors, LLC

$20.3 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $46,300 - $220,444	-69,105 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$2.22 - $3.45 $10,775 - $16,746	4,854 Added 7.55%	69,105 $206,000
Q4 2021 Feb 15, 2022	SELL	$2.36 - $3.57 $102,159 - $154,538	-43,288 Reduced 40.25%	64,251 $170,000
Q3 2021 Nov 12, 2021	BUY	$3.5 - $4.5 $57,631 - $74,097	16,466 Added 18.08%	107,539 $390,000
Q2 2021 Aug 12, 2021	BUY	$3.09 - $4.54 $71,888 - $105,623	23,265 Added 34.31%	91,073 $395,000
Q1 2021 May 13, 2021	SELL	$3.35 - $4.93 $224,242 - $330,004	-66,938 Reduced 49.68%	67,808 $232,000
Q4 2020 Feb 08, 2021	BUY	$2.35 - $3.74 $148,729 - $236,700	63,289 Added 88.57%	134,746 $471,000
Q3 2020 Nov 12, 2020	BUY	$1.78 - $4.13 $24,587 - $57,047	13,813 Added 23.96%	71,457 $171,000
Q2 2020 Aug 12, 2020	SELL	$1.41 - $2.05 $2,174 - $3,161	-1,542 Reduced 2.61%	57,644 $105,000
Q1 2020 May 13, 2020	BUY	$1.27 - $3.0 $7,943 - $18,765	6,255 Added 11.82%	59,186 $92,000
Q4 2019 Feb 07, 2020	SELL	$1.6 - $2.43 $1,824 - $2,770	-1,140 Reduced 2.11%	52,931 $113,000
Q3 2019 Nov 12, 2019	SELL	$1.63 - $2.62 $145,772 - $234,309	-89,431 Reduced 62.32%	54,071 $101,000
Q2 2019 Aug 14, 2019	BUY	$2.02 - $2.61 $27,938 - $36,098	13,831 Added 10.67%	143,502 $374,000
Q1 2019 May 10, 2019	BUY	$2.0 - $2.65 $33,096 - $43,852	16,548 Added 14.63%	129,671 $333,000
Q4 2018 Feb 14, 2019	BUY	$2.08 - $3.36 $38,529 - $62,240	18,524 Added 19.58%	113,123 $260,000
Q3 2018 Nov 14, 2018	BUY	$2.6 - $3.59 $36,319 - $50,148	13,969 Added 17.32%	94,599 $303,000
Q2 2018 Aug 14, 2018	BUY	$2.83 - $4.11 $71,686 - $104,110	25,331 Added 45.81%	80,630 $228,000
Q1 2018 May 10, 2018	BUY	$3.54 - $4.54 $195,758 - $251,057	55,299 New	55,299 $195,000

Others Institutions Holding RIGL

# of Institutions

Shares Held

334K

Call Options Held

Put Options Held

View Full List

About RIGEL PHARMACEUTICALS INC

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.95B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

More about RIGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account